Pfizer Inc., Roche Holding AG (JOBS), Bayer AG, and Wyeth Cancer Drugs Rejected by U.K. Agency on Cost

August 8, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Aug. 7 (Bloomberg) -- Pfizer Inc., Roche Holding AG, Bayer AG and Wyeth's cancer treatments were rejected for use in advanced kidney cancer patients in a preliminary recommendation by a U.K. panel that studies the cost-effectiveness of medicines.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research

Pfizer